Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 9/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 9/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20425444 | 0.86 | MTNR1A (0.42) | KMT2AMTNR1AMTNR1BMAOBNPC1 | |
| SCHEMBL1515892 | 0.74 | NFE2L2 (0.49) | NFE2L2KMT2AMAOBMGLLSMN1; SMN2 | |
| SCHEMBL8487888 | 0.72 | ATM (0.43) | NFE2L2KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL9401354 | 0.71 | GAA (0.39) | SMN1; SMN2 | |
| SCHEMBL10297508 | 0.69 | MTNR1A (0.55) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL3817562 | 0.69 | NPSR1 (0.42) | KMT2AMAOBNPC1RAB9AALDH1A1 | |
| SCHEMBL9621618 | 0.69 | MTNR1A (0.59) | MTNR1AMTNR1BTERTALDH1A1 | |
| SCHEMBL8190479 | 0.67 | MTNR1A (0.46) | KMT2AMTNR1AMTNR1BNPC1RAB9A | |
| 1,3-Dimethoxybenzene SCHEMBL27445411 | 0.67 | MAOB (0.65) | NFE2L2MAOBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6991476 | 0.66 | MAOB (0.51) | NFE2L2KMT2AMAOBMGLLNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912033-A1 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | The Board of Trustees of the University of Illinois (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2911660-A1 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | The Board of Trustees of the University of Illinois (US) | 2015-09-02 | — | — | EP | disclosed |
| WO-2014066695-A1 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2014-05-01 | — | — | WO | disclosed |
| WO-2014066692-A1 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2014-05-01 | — | — | WO | disclosed |
| EP-1334094-A1 | CHOLESTEROL LOWERING BENZO[B]THIOPHENES AND BENZO[D]ISOTHIAZOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002036584-A1 | CHOLESTEROL LOWERING BENZO`B! THIOPHENES AND BENZO`D! ISOTHIAZOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-10 | — | — | WO | disclosed |